23andMe was founded in 2006 as a direct-to-consumer genetics testing specialist and became a publicly traded company in June 2021, trading under the ticker symbol « ME. » At.
What just happened? DNA testing specialist 23andMe has filed for Chapter 11 bankruptcy protection in order to facilitate a sale. Mark Jensen, chair and member of the special committee of the board of directors, said that after a thorough evaluation, it was decided that a court-supervised sale process would be the best path forward to maximize the value of the business.
23andMe was founded in 2006 as a direct-to-consumer genetics testing specialist and became a publicly traded company in June 2021, trading under the ticker symbol « ME. » At the time, co-founder and CEO Anne Wojcicki said the company had over 11 million users that were using genetics to transform how they diagnose, treat, and prevent human disease.
